- Home
- HSCS vs ALLR Comparison
HSCS vs ALLR Comparison
Compare HSCS & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- ALLR
- Stock Information
- Founded
- HSCS 2007
- ALLR 2004
- Country
- HSCS United States
- ALLR United States
- Employees
- HSCS N/A
- ALLR N/A
- Industry
- HSCS Medical Specialities
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- ALLR Health Care
- Exchange
- HSCS Nasdaq
- ALLR Nasdaq
- Market Cap
- HSCS 2.7M
- ALLR 2.3M
- IPO Year
- HSCS 2022
- ALLR N/A
- Fundamental
- Price
- HSCS $2.67
- ALLR $1.25
- Analyst Decision
- HSCS Strong Buy
- ALLR
- Analyst Count
- HSCS 1
- ALLR 0
- Target Price
- HSCS $15.00
- ALLR N/A
- AVG Volume (30 Days)
- HSCS 26.2K
- ALLR 269.8K
- Earning Date
- HSCS 12-12-2024
- ALLR 11-14-2024
- Dividend Yield
- HSCS N/A
- ALLR N/A
- EPS Growth
- HSCS N/A
- ALLR N/A
- EPS
- HSCS N/A
- ALLR N/A
- Revenue
- HSCS $18,600.00
- ALLR N/A
- Revenue This Year
- HSCS $8,948.39
- ALLR N/A
- Revenue Next Year
- HSCS $27.27
- ALLR N/A
- P/E Ratio
- HSCS N/A
- ALLR N/A
- Revenue Growth
- HSCS 853.85
- ALLR N/A
- 52 Week Low
- HSCS $2.36
- ALLR $1.15
- 52 Week High
- HSCS $29.00
- ALLR $666.00
- Technical
- Relative Strength Index (RSI)
- HSCS 40.14
- ALLR 35.03
- Support Level
- HSCS $2.53
- ALLR $1.16
- Resistance Level
- HSCS $2.76
- ALLR $1.53
- Average True Range (ATR)
- HSCS 0.17
- ALLR 0.10
- MACD
- HSCS 0.02
- ALLR 0.02
- Stochastic Oscillator
- HSCS 22.83
- ALLR 28.95
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.